Indication
Hormone Receptor-positive Metastatic Breast Cancer
1 clinical trial
2 products
Clinical trial
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management. The MINERVA Trial - A Phase IV TrialStatus: Recruiting, Estimated PCD: 2029-04-01
Product
Abemaciclib + Fulvestrant